The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2020

Filed:

Dec. 10, 2015
Applicants:

The General Hospital Corporation, Boston, MA (US);

Novartis Ag, Basel, CH;

Inventors:

Qing Sheng, Sharon, MA (US);

Rakesh K. Jain, Freemont, CA (US);

Vasileios Askoxylakis, Cambridge, MA (US);

Gino B. Ferraro, Somerville, MA (US);

Dai Fukumura, Newton, MA (US);

David P. Kodack, Boston, MA (US);

Assignees:

Novartis AG, Basel, CH;

The General Hospital Corporation, Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/32 (2006.01); A61K 31/5377 (2006.01); C07K 16/30 (2006.01); A61K 45/06 (2006.01); A61P 35/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/32 (2013.01); A61K 31/5377 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61P 35/04 (2018.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present invention relates to a pharmaceutical combination which comprises (a) a phosphatidylinositol 3-kinase inhibitor or pharmaceutically acceptable salt thereof, and (b) a Her3 antagonist, for simultaneous, separate or sequential administration for the treatment of breast cancer brain metastases; a method of treating a subject having a breast cancer brain metastases comprising administration of said combination to a subject in need thereof; use of such combination for the treatment of breast cancer brain metastases; and a commercial package comprising such combination.


Find Patent Forward Citations

Loading…